Prestige Wealth Management Group LLC Zynerba Pharmaceuticals, Inc. Transaction History

Prestige Wealth Management Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.72 - $5.35 $1,674 - $2,407	-450 Closed	0 $0
Q3 2020 Oct 26, 2020	SELL	$3.23 - $4.3 $12,920 - $17,200	-4,000 Reduced 89.89%	450 $1,000
Q2 2020 Aug 13, 2020	BUY	$3.31 - $6.54 $1,489 - $2,943	450 Added 11.25%	4,450 $15,000
Q2 2019 Aug 16, 2019	BUY	$5.4 - $15.5 $21,600 - $62,000	4,000 New	4,000 $54,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.